结合MELD-XI得分和血液动力学参数,可提高经过过导管三门干预手术的患者的短期预后值
Johannes Schlegl1,2, Marwin Bannehr1,2, Tanja Kücken1,2
1Department of Cardiology, Heart Center Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Berlin, Ladeburger Straße 17, 16321, Germany.
Wiener klinische Wochenschrift
|January 14, 2026
概括
MELD-XI得分有效预测了经过过导管三门干预 (TTVI) 的患者的死亡率. 将MELD-XI与血液动力学数据相结合,进一步提高了TTVI后死亡率和再住院的预后准确性.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 干预心脏病学 干预心脏病学
背景情况:
- 肝功能障碍是症状三管回 (TR) 患者的关键预后指标.
- 评估肝脏和脏功能以及心脏血液动力学对于预测接受干预的TR患者的结果至关重要.
研究的目的:
- 评估末期肝病模型 (MELD) 和MELD-XI得分的预后能力,以及右心动力学参数.
- 确定这些参数的预测值,以确定经过过导管三门干预 (TTVI) 后的死亡率和再住院.
主要方法:
- 一项前性,单中心的队列研究,涉及接受TTVI (边缘对边缘或异型修复) 的患者.
- 使用肌素,胆红素和INR计算MELD和MELD-XI得分.
- 进行了右心脏导管治疗,接收器操作特征 (ROC) 分析评估了分数和血液动力学参数的预测值,用于3个月死亡率或再住院的复合终点.
主要成果:
- 两种MELD (AUC 0.91) 和MELD-XI (AUC 0.96) 评分都显示出对死亡率的良好预测价值.
- 预干预MELD-XI,右心室压力,右心房压力和肺动脉压力预测了复合终点.
- 将血动力学参数 (PA,RA,RV压力) 与MELD-XI得分相结合,提高了其对复合终点 (AUC 0.91) 的预测值.
结论:
- MELD-XI得分显示,作为预测TTVI后3个月死亡率的风险分层工具,它是有前途的.
- 将侵入性血液动力学测量纳入MELD-XI得分可以显著改善其对组合不良结果的预后性能.
相关概念视频
01:22Mitral Valve Prolapse II: Assessment and Management
411
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
411
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
215
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
215